All In MedTech

Device Trial Radar · NCT04829994

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

A Long Term Prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT EXACT® Continence System for the Treatment of Stress Urinary Incontinence

Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

198

Actual

Start

Jul 7, 2021

Primary completion

Sep 30, 2030

Study completion Sep 30, 2035

Sponsor

Lead sponsor
Ethicon, Inc.Public (JNJ)
Sponsor type
Industry
First posted
Apr 2, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT EXACT® Continence System in women undergoing retropubic mid-urethral sling surgery for Stress Urinary Incontinence (SUI).

Conditions

  • Stress Urinary Incontinence

Interventions

  • InterventionDevice

    There is no intervention, beyond necessary clinical care, in this study. The surgical procedures being performed within the study are identical to the surgical procedures subjects would receive as part of SOC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cough Stress Test (CST) Assessment ChangeTime frame: Post-surgery through study completion, approximately 5-10 yrs

Locations

8 sites in 6 countries. Site status is shown where the registry gives one.

  • Duke University

    Durham, North Carolina

  • Institute for Female Pelvic Medicine

    North Wales, Pennsylvania

  • UPMC

    Pittsburgh, Pennsylvania

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.